Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Biotechnology has been a global industry for years, yet patent laws and agencies are still mostly national in scope. Not surprisingly, smaller biotech businesses, often cash-strapped and limited to the knowledge of their management and investors, find it a hurdle if they intend to grow into successful global enterprises. Industry advocates are looking to help those smaller companies protect their patents for treatments, technologies, and other intellectual property; details here. How to help is under study by the US Patent and Trademark Office (USPTO), which is compiling recommendations for helping smaller businesses in and outside the life sciences gain international patent protection. Among questions the USPTO report is intended to answer is what role, if any, should the federal government play. What do think?